Skip to content

Zymeworks ZYME Net margin

Net margin at other companies

Pfizer logo
PfizerPFE
15.7%
Amgen logo
AmgenAMGN
21%+3.6pp
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
-49.9%-22.6pp
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
-181.7%-77.9pp
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
-508.5%-254pp
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
-529.2%-556pp

Other financials

Income statement

See full
Revenue$2.4M-91.1%
Operating income-$47.1M-84.0%
Net income-$44.2M-95.1%
EPS (diluted)-$0.59-96.7%

Balance sheet

See full
Cash & equivalents$244.3M+221%
Total debt$17.0M-7.7%
Total equity$163.6M-49.7%
Total assets$478.2M+12.4%

Cash flow

See full
Operating cash flow-$45.7M-1,242%
CapEx$216.0K+1,250%
Free cash flow-$45.9M-1,242%

Valuation

See full
Market cap$1.76B+125%
Enterprise value$1.53B+112%
P/S21.6×+13.2×

Profitability

See full
Operating margin-140.4%+7.3pp
FCF margin-94.8%+15.5pp

Returns & leverage

See full
Return on equity-42%+29.2pp
Debt / equity0.1×0.0×
Current ratio10.8×+6.1×

Where this comes from

Calculated from Zymeworks’s reported figures.

Based on trailing twelve months.

The official record: Zymeworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zymeworks's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zymeworks's net margin?
Zymeworks (ZYME) reported net margin of -126.3% in Q1 2026.
How has Zymeworks's net margin changed year-over-year?
Zymeworks's net margin decreased by 3.8% year-over-year, from -121.7% to -126.3%.
What is the long-term trend for Zymeworks's net margin?
Over 4 years (2020 to 2025), Zymeworks's net margin has grown at a -36.2% compound annual growth rate (CAGR), from -463.5% to -76.6%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.